Free Trial

Straumann Holding AG (OTCMKTS:SAUHY) Given Consensus Rating of "Buy" by Analysts

Straumann logo with Medical background

Key Points

  • Straumann Holding AG has received an average consensus rating of "Buy" from five analysts, with two holding and three issuing strong buy ratings.
  • The stock price of Straumann is currently at $10.78, with a 52-week range between $10.30 and $15.62.
  • Straumann specializes in dental implants, orthodontic solutions, and related services, operating on a global scale.
  • Five stocks we like better than Straumann.

Shares of Straumann Holding AG (OTCMKTS:SAUHY - Get Free Report) have received an average rating of "Buy" from the five ratings firms that are presently covering the stock, Marketbeat Ratings reports. Two analysts have rated the stock with a hold rating and three have issued a strong buy rating on the company.

Several equities analysts have recently issued reports on the company. Deutsche Bank Aktiengesellschaft reiterated a "hold" rating on shares of Straumann in a research report on Wednesday, October 1st. The Goldman Sachs Group downgraded Straumann to a "neutral" rating in a research report on Monday.

View Our Latest Stock Report on Straumann

Straumann Stock Up 0.4%

OTCMKTS:SAUHY opened at $10.78 on Tuesday. The stock has a 50 day moving average of $11.56 and a 200-day moving average of $12.27. Straumann has a 52 week low of $10.30 and a 52 week high of $15.62.

About Straumann

(Get Free Report)

Straumann Holding AG provides tooth replacement and orthodontic solutions worldwide. It researches, develops, manufactures, and supplies dental implants, instruments, CADCAM prosthetics, orthodontic aligners, biomaterials, and digital solutions for use in tooth correction, replacement, and restoration, as well as to prevent tooth loss.

Further Reading

Analyst Recommendations for Straumann (OTCMKTS:SAUHY)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Straumann Right Now?

Before you consider Straumann, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Straumann wasn't on the list.

While Straumann currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.